Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Jul 28, 2026

GLUE — Monte Rosa Therapeutics, Inc. Dilution Risk Tracker

Track GLUE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLUE — Get alerts when the score changes →

As of July 28, 2026, Monte Rosa Therapeutics, Inc. (GLUE) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Monte Rosa Therapeutics, Inc. has a market capitalization of $1.67B, 84.48M shares outstanding, 191 institutional holders tracked. Key dilution vectors include approximately 13 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
35
⚠️ Warrant Exposure
40
🔄Convertible Debt—

Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GLUE.
🔔 Track GLUE — Get forecast alerts →

Market Data

Market Cap$1.67B
Shares Outstanding84.48M
Float52.94M
Cash$159.86M
Debt$39.06M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 41.7% shares (2026Q1 vs prior)
191 institutional holders · 93.33M shares
#1 NEA Management Company, LLC 7.69M shares
#2 PRICE T ROWE ASSOCIATES INC /MD/ 6.72M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 6.20M shares
+ 17 more holders Sign up free to view →

Short Interest

Short Interest17.20M
Days to Cover13.1
% of Float32.5%
FINRA data as of Jul 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-06-30
Full SEC filing analysis available with free account →

Recent News

No recent news

What This Means for GLUE Shareholders

Monte Rosa Therapeutics, Inc. (GLUE) has a DilutionScore of 41/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 28, 2026.

Cash runway is a key watch item: GLUE has approximately 13 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for GLUE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for GLUE alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track GLUE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLUE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT AHRT ALOT AMPH AMPY

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GLUE
GLUE FDA Catalyst Timeline & Biotech Grade — BiotechSignsGLUE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.